Posted by AGORACOM-JC
at 4:24 PM on Thursday, December 30th, 2021
FOBI AI is a global leader in digital wallet pass technology that delivers real-time data analytics and engagement through artificial intelligence to drive customer activation and engagement in stores, stadiums, arenas, hotels and other large venues around the world.
More than just lip service, FOBI AI is firing on all cylinders. Here are just some of the highlights from December:
Posted by AGORACOM-JC
at 10:18 AM on Saturday, December 25th, 2021
The Roundup
A weekly summary of Novamind news and media
Dr. Steve Thayer with an important reminder that, for some, the holidays can be a difficult time of year for many reasons. He shares tips to care for our mental health and wellbeing over the holidays.
We are pleased to announce the signing of a definitive agreement to acquire Arizona-based Foundations for Change, a mental health practice specialized in ketamine-assisted psychotherapy, from its sole stockholder, Jeff Edelman. The transaction is subject to regulatory approvals and is expected to close in January 2022.
Opened in 2017 by Jeff Edelman, Foundations currently operates one outpatient mental health clinic in Peoria, Arizona with an annual revenue run rate in excess of US$800,000 and owns a second, larger location in Phoenix that is scheduled to open in early 2022. Foundations will temporarily operate as “Foundations for Change by Novamind” until the Company completes its recently announced rebrand. Mr. Edelman will continue in a leadership capacity as Medical Director for both clinics. Mr. Edelman is double board-certified Family Psychiatric-Mental Health Nurse Practitioner and a Child and Adolescent Psychiatric-Mental Health Clinical Nurse Specialist. As a former military combat veteran, who served in the US Army 55th Medical Co. Combat Stress Control unit, Mr. Edelman has special expertise in treating military veterans and first responders who struggle with stress and trauma.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison catch up after their recent trip to the “Horizons: Perspectives on Psychedelics” conference in New York. Stay tuned next week for our last episode of 2021 and a special PTF podcast contest and giveaway.
NBC News reports on a first-of-its kind clinical trial at the University of Washington School of Medicine to treat 30 medical professionals experiencing depression with a dose of synthetic psilocybin combined with psychotherapy. Some say that even five years ago, this would have been considered taboo. “That medical researchers are turning toward psilocybin to treat colleagues is representative of a growing curiosity and acceptance of the drug among those in the medical establishment.” We’re seeing that openness, too, through our Frontline KAP clinical pilot to help healthcare workers heal.
Posted by AGORACOM-JC
at 5:20 PM on Tuesday, December 21st, 2021
We all remember the crash of “blockchain” stocks a couple of years back, which was actually a crash of blockchain pretenders who used the term to build stock promotions, as opposed to building actual blockchains.
Like the dot-com crash of 2000, which bankrupted “dot-com” companies but gave birth to the likes of Google, Amazon, Linkedin because they built actual utility and value, the same could be expected of the blockchain crash and its’ resurgence.
But Blockchain Foundry is only just getting started. The Company is building a WEB3 ecosystem on top of its powerful Sycoin blockchain which is the 2nd most secure blockchain in the world next to Bitcoin. That isn’t a typo and Web3 coin investors believe it given the fact it has traded over $13,000,000 in volume over the last 24 hours … and close to $25,000,000 in the 24 hours before that!
What do they know that small cap investors don’t know? What to Web3 investors know that isn’t being reflected in the $BCFN stock price? The short answer is .. A Lot … but luckily we were able to tear away CEO Dan Wasyluk from his coding marathons to explain exactly what we are missing by going through the Company’s power point presentation.
If you’re a small cap investor looking for exposure to the Web3 world of blockchain, coins, tokens, NFTs and more then this $BCFN presentation is a must-watch.
Posted by AGORACOM
at 12:00 PM on Monday, December 20th, 2021
Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) (FWB:6F6) provides investors access to a diverse portfolio of next generation technology companies in key sectors, including: Web 3.0, Blockchain, Gaming, the Creator Economy, NFTs and the Metaverse.
“We are living in the midst of the 4th Industrial Revolution; The Tech Revolution that will undoubtedly change everything as we know it,” says VST CEO Shafin Diamond Tejani.
“Web 3.0, Blockchain, Gaming, VR/AR, the Creator Economy, Digital Health and Climate Tech are all sectors that Victory Square has invested in. We offer investors the chance to invest in the most exciting tech trends all in one place with a uniquely liquid, audited and secure way to gain access to these latest innovative technologies.”
Across the next 120 days, VST’s primary goals will be to:
Issue The Second Tranche Of a Special Common Share Dividend of its Interest in Portfolio Company Fantasy 360 Technologies Inc. (dba Immersive Tech)
Assist Stardust Solar Technologies Inc., Turnium Technology Group Inc., Cassia Research Inc. (doing business as CoPilot.AI) and Shop and Shout Ltd. (doing business as Creator.co) with considering and preparing for potential public listing transactions.
Ramp up sales and marketing to provide Victory Square Digital Health’s full-suite of mobile digital health solutions and telemedicine platform to surgery centres, skilled nurses, home care agencies and hospice care.
Work with Victory Square Health to grow the Company’s roster of diagnostic tests and expand its digital health business within Brazil, the U.S. and Canada.
Work with Creator.co to complete the development of an add-on feature which will allow creators to launch their own digital currency powered by the blockchain.
Successfully incubate next batch of VST projects working on the following: Exchange Traded Protocols (Metaverse, DeFi, GameFi, DAOs), P2E (Play to Earn) Games, Decentralized Social Networks (DeSo Creator Platform).
Against this backdrop, Agoracom founder George Tsiolis sat down with the CEO to discuss the shape of the future…
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Jeremiah Robison to talk about work-life balance. Jeremiah is the Founder and CEO of Shroom Beach, a psychedelic-inspired clothing company that donates 10% of its profits to fund psychedelic medicine research
Both articles highlight how the new clinic will focus on treating substance use disorders and addiction-related illnesses led by incoming medical director Amy de la Garza.
Blossom summarizes the exciting progress made on treating eating disorders with psychedelics. It’s a passion which our Chief Medical Officer, Dr. Reid Robison shares, working for years to bring innovative and effective treatment options to people suffering. Recently, Dr. Robison presented a keynote on the topic at the MindMed Australia International Summit on Psychedelic Therapies for Mental Illness. You can watch it here.
Three more Canadians received legal access in a big win that “opens it up to everyone,” but there are still issues with the system overall. “The process is still broken.” The Vancouver Sun explores how even with such positive news, there is still a lot of ground to cover in Therapsil’s fight for expanded access to psychedelic medicine.
No. We are not out of the woods. The Omicron variant is spreading quickly and with it, a slew of public health restrictions and fears reminiscent of March 2020. What can’t get lost in the shuffle again is addressing mental health. Especially for those on the frontlines of healthcare. “This sense of endlessness, accompanied by growing psychological distress leading to depression, was a recurrent theme in two dozen interviews conducted in Asia, Europe, Africa and the Americas. After two years of zigzagging policy and roller coaster emotions, terrible loss and tantalizing false dawns, closing borders and intermittently shuttered schools, people’s resilience has dwindled.” Frontline ketamine-assisted psychotherapy registration is still open for the next group of participants. Learn more here.
Posted by AGORACOM-JC
at 4:38 PM on Friday, December 17th, 2021
Valeo Pharma is already a successful, revenue-generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
Q3 Highlights:
Record revenues of $5.7 million for Q3 2021, up 280% over Q3 2020 and 114% over prior quarter.
Record gross margin of $2.2 million , up 1602% over Q3 2020 and 204% over prior quarter.
Record 9 months revenues at $10.2 million , up 94%
Public reimbursement now includes Alberta , Quebec and Nova Scotia , representing approximately 37% of the Canadian population.
More than 90% private insurance coverage across Canada
Frederic Fasano, Valeo’s President and Chief Operating Officer commented,
“We are pleased to be reporting today the addition of Quebec and Nova Scotia to join Alberta on the list of provincial public coverage secured for both asthma medications. Public Reimbursement access makes a meaningful impact for asthma patients left with no coverage so far, and also simplify health care providers procedures to provide access of both medications to their patients. Enerzair and Atectura are innovative asthma therapies that are helping make asthma control a more attainable goal for Canadians asthma patients”.
Posted by AGORACOM
at 4:43 PM on Thursday, December 16th, 2021
Cross River Ventures is focused on the development of top tier exploration properties in the premier mining district of Red Lake Ontario exploring for gold, and for several good reasons.
The Red Lake Mining jurisdiction hosts one of the largest mineral rich greenstone belt on the planet that has produced 200 million ounces of gold in over 100 years of mining. This includes a total gold endowment exceeding 300million ounces with over 124 mines and 21 plus deposits with more than 3 million ounces each.
Cross River hosts 7 Projects (over 28,000-hectares) within the prolific greenstone belts of NW Ontario, Canada which host the most productive gold deposits in the world.
This is where Cross River is targeting gold for discovery potential.
Armed with a world class technical team led by Dr. Rob Carpenter, who was the CEO of Kaminak, ( acquired by Goldcorp for CDN $520 million), know how to plan and execute a exploration program designed specifically to make a discovery.
Cross Rivers Flagship McVicar Property is just one of the properties they are targeting for discovery. Situated close to the 3.8m Oz Springpole deposit controlled by First Mining Gold Corp. ( FF.TO ) it hosts 2 mineralized trends that are parallel to one another and include new surface discoveries of gold, as well as previous sampling of high grade with numerous results greater than 500g/t gold.
McVicar is ready to be fully explored and drill permits for the property have been issued for multiple target areas delineated via modern geophysics.
The recent driver of attention to the Red Lake area is the takeover of Great Bear Resources by Kinross Gold Corp. under which Kinross has agreed to acquire all of the outstanding common shares of the Red Lake explorer for C$29.00 per share, approximately $1.8-billion and being done without a resource calculation. This is primarily due to the excellent nature of their drill results.
The peer takeover speaks to the attractiveness of discovery potential and quality of the mining jurisdiction. Cross River is in the right neighborhood to make a discovery, at the right time in the market, and when attention in the area has never been greater.
Sit back and enjoy this great interview with Cross River Venture CEO Alex Klenman as he walks us through their objective to make a discovery equal to their peers in the Red Lake Mining District.
Review confirms Q by SoLVBL’s security, reliability and operational excellence, while reducing overall operational workload risks for cloud-based applications.
The Functional Technical Review (“FTR”) also confirmed the speed and functionality of Q by SoLVBLTM, as well as providing SoLVBL with data required to develop a cost model.
This successful trial, with all objectives achieved, will enhance SoLVBL’s continuing marketing and sales efforts.
SoLVBL Solutions and Empower Clinics Sign Memorandum of Understanding (MoU) to Develop a Program for Data Security in Diagnostic Testing
“We are excited to collaborate with SoLVBL Solutions, a company with broad know-how in data verification and cybersecurity. The collaboration agreement entered with Empower combines SoLVBL Solutions’ data verification capabilities with Empower’s experience and extensive expertise in the design, construction, operation, and maintenance of healthcare clinics and world-class diagnostic laboratories. With the increase in data collection, the demand to protect and verify data is unprecedented. We have seen such announcements come from both the Canadian and American governments. We feel this verification solution will allow us to continue to grow and meet the demands and needs of our patients and health care administrations. The collaboration aligns with our expansion and growth plans to become a global technological leader in the healthcare diagnostic sector.” said Steven McAuley, CEO of Empower.
Data Security Today
We live in a digital data age
Data is critical for the present and future of automation, AI, IoT, analytics etc.
As decisions become more automated, data integrity becomes even more crucial
The cyber security market size was valued at $149.67 billion in 2019 and is projected to reach $304.91 billion by 2027
North America accounts for 45% of market
Data Forgery
Data is the “new gold”
Forgery, hacking is a growing problem in the data world.
In a world increasingly reliant upon more and faster data for automated decision-making, operational efficiency and competitive advantage, data integrity and protection is critical to ensure a client’s data is not a liability.
Solving the problem
In the physical world fraud can be detected by using physical tools to detect alterations, such as hand writing analysis, watermarks, age of paper etc. In the digital world, which comprises of 1’s and 0’s, there is no way of knowing if the 1’s and 0’s have been altered, unless you use Q by SoLVBL.
Q by SoLVBL
So… what technology does this replace?
Q by SoLVBL™ operates dramatically faster and at lower latency than the alternative today, Digital Ledger Technology (DLT)—commonly referred to as Blockchain. This in turn enables data uses and applications DLT does not support.
The Q by SoLVBL™ protocol produces a unique digital seal for each submitted record.
What can this technology be used for?
Link the record to the possessor of a private signing key, i.e. an identity
Determine relative ordering of records sealed in this manner
Uniquely identify an instance of the record by way of its seal (each seal reflects an instance)
Is Q by SoLVBL™ difficult / expensive to implement? Or is it an add-on?
Cost-effective to implement
May be integrated with existing application in a straightforward manner, wherever data is created, stored or used.
Whether Q by SoLVBL™ is applied as an add-on or technology replacement depends on the architecture needs and maturity of the system in which it is used.
Who are the company’s competitors?
Users seeking such assurances will typically gravitate towards various Blockchain or Distributed Ledger Technologies (DLT).
Significant shortcoming of DLT is that the inherently decentralized nature of these technologies causes them to impose prohibitive latency or bandwidth limitations on their users.
Q by SoLVBL™ can process 150,000 transactions per second at a minimum, and millions per second depending upon the application.
Our Vision “Our dream is a world in which every digital record’s authenticity can be established quickly and irrefutably to create trust fast.”
Our Mission “To empower better, faster decisions by developing a universal standard for establishing digital record authenticity which is easy to adopt, cheap to use, offers cryptographic assurances, and will not bottleneck systems.”
**
WHY SOLVBL
SoLVBL’s innovative integrity solutions give clients and customers added trust to ensure their data is an asset
Cost of data security is significant
The finance and insurance sector were the most- attacked industry in 2019, with retail payments second
Data security & privacy segment expected to outpace total cyber security growth
Data is valuable and important. Should be asset not liability
Highlights
– Q by SoLVBL is a cryptographically verified, patented, best-in-class cybersecurity product;
– Q by SoLVBL is simple to use;
– Enhanced confidentiality, by never needing to see your data;
– It is compatible with existing systems, so no expensive hardware/software updates;
– Q by SoLVBL is fast. Q can process in excess of 150,000 transactions/second; and
– Our Software as a Service (SaaS) model is very cost effective to the client.
– SoLVBL announces first Memorandum of Understanding (MoU) in the Financial Services Sector, with QuantGate Systems to Develop a Program for Data Security
– Allow to further demonstrate its capabilities around data security and speed of transactions
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza
We are pleased to announce the opening of a new clinic located in downtown Salt Lake City (SLC). In addition to Novamind’s suite of mental health treatments, the SLC Clinic specializes in integrative behavioural health and services for adults with substance use disorders (SUD) led by incoming Medical Director, Dr. Amy de la Garza.
The SLC Clinic’s outpatient SUD services provide an alternative to residential treatment programs and work to address the highly complex public health crisis that is worsening alongside challenges related to access. In 2020 alone, 93,000 Americans died of a drug overdose-an increase of 30 per cent from the previous year, according to the Centers for Disease Control and Prevention.
Dr. Reid Robison, Novamind’s Chief Medical Officer, commented: “Social isolation and despair related to the COVID-19 pandemic have further fueled a significant increase in substance use disorders and related deaths. Dr. de la Garza’s expertise in addiction medicine and behavioural health is a vital addition to our team as we continue to expand Novamind’s clinic footprint to address unmet need and broaden our innovative, evidence-based treatments.”
Dr. de la Garza is a board-certified family practice physician with 10 years of experience providing specialized care for patients with behavioral health and SUD diagnoses. She earned her Doctorate in Medicine from the University of Colorado before completing a Family Medicine Residency at the Utah Healthcare Institute. She also completed an Addiction Medicine Fellowship at the University of Utah and is an Institute for Functional Medicine Certified Practitioner. In 2017, Dr. de la Garza opened the first community-based, co-located primary care and behavioral health practice in Salt Lake City, Utah.
“I am thrilled to join Novamind and look forward to establishing an innovative outpatient substance use disorder program that brings together addiction and integrative medicine and treats the whole person,” said Dr. de la Garza, who is also trained in integrative modalities and lifestyle medicine, including nutrition, movement, sleep, stress management and social connection.
Novamind will collect clinical data on the efficacy of the integrative treatment approach for SUD and host upcoming studies for conditions like opioid use disorder. Additionally, the SLC Clinic will pilot an innovative and cost-effective group medical visit model that has been shown to reduce anxiety and depression, as well as improve outcomes in chronic conditions like cardiovascular disease and diabetes.
The SLC Clinic is located at 807 E South Temple, Suite 101, Salt Lake City, Utah.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore anxiety. They discuss the following topics and much more: • What is an anxiety disorder? • Anxiety management skills • The role of medicines in treating anxiety
Utah Business covers Dr. Reid Robison and the success of ketamine-assisted psychotherapy in our clinics. “While it’s still early and much more testing is to be done, Robison describes what’s happening in mental health care as a ‘psychedelic renaissance’.”
Dr. Reid Robison, Matt Johnson and Robin Carhart-Harris discuss The Science of Psychedelics: Therapeutic mechanisms and clinical outcomes for a range of mental illnesses and other conditions.
Chief Medical Officer Dr. Reid Robison’s keynote presentation at the Mind Medicine Australia International Summit on Psychedelic Therapies for Mental Illness.
“While the U.S. has been battling Covid-19 it’s gotten lost in the shuffle that the nation had record numbers of drug overdose-related deaths in 2020; approximately 93,000. In addition, from May 2020 through April 2021, the figure rises to 100,000.” We need better treatment options for people with substance use disorders (SUD). It’s the driving force behind why incoming Novamind Medical Director Dr. Amy de la Garza will lead SUD programming at our new Salt Lake City clinic.
We are currently in a mental health crisis. Depression, anxiety and symptoms of PTSD have run rampant over the last two years, accelerated by the COVID-19 pandemic and its far-reaching effects. The need for new and effective mental health treatments has never been clearer. We have seen the efficacy of ketamine-assisted psychotherapy firsthand. And we are eager to continue psychedelic research. If you’d like to stay up to date on upcoming studies hosted by Novamind, visit us here and get in touch. “So what else does the future hold for psychedelics? For one thing, taking psychedelics could one day be the same as taking an everyday pill prescribed by your doctor.”
Posted by AGORACOM-JC
at 5:48 PM on Thursday, December 9th, 2021
Kidoz (KIDZ: TSXV) owns the biggest mobile advertising platform for kids and families. How big? There are almost 4,000 apps around the world using Kidoz, reaching over 300 MILLION kids. The company works with top brands, including Disney, McDonald’s, Hasbro, and Lego, and is a trusted partner of Apple and Google.
Total Revenue of $2,814,642 – growth of 47% compared to Q3 2020 Total Revenue of $1,919,973 and growth of 29% from revenue of $2,177,505 for the second quarter of 2021.
Gross Profit of $1,226,534 – growth of 34% compared to Q3 2020 Gross Profit of $914,657 and growth of 20% from Gross Profit of $1,024,333 for the second quarter of 2021.
Adjusted EBITDA of $265,984 compared to an adjusted EBITDA of $16,484 for Q2 2021.
We sat down with Kidoz Inc. Co-CEOs Jason Williams & Eldad Ben Tora to discuss their recently announced Programmatic Solution “Kidoz Connect”.
This new product release is a unique programmatic solution providing ‘review & monetize’ technology to enable open market ad sourcing at scale. Kidoz Connect enables any brand, agency or DSP to programmatically reach the Kidoz unique inventory of over 300 million users accessible in a fully COPPA/GDPR compliant manner, through a single point of integration.
This new technology could increase impressions sold by 3-5X.
Co-CEO Eldad Ben Tora commented,
“Kidoz Connect is currently live with select launch partners and we are actively developing and integrating a number of new sources that will together create the pipeline of programmatic ad campaigns available to Kidoz’s app publisher network. As Kidoz advances its multiple product offerings, new opportunities arise in the bountiful mobile advertising ecosystem that is projected by eMarketer to exceed over US$400 billion by 2023 (eMarketer). Kidoz is perfectly positioned with powerful technology in a booming market and management anticipates a record Q4 and 2022 ahead.”
Now sit back, relax and watch this powerful interview with Co-CEOs of Kidoz Inc.
